Comparably, PD-1 expression on tumor-infiltrating mDCs has also been shown to suppress CD8+ T cell activity and decrease T cell infiltration in mouse models for advanced ovarian cancer (89) and hepatocellular carcinoma (90). The gene discussed is CD8A; the disease is neoplasm.